Free Submission Public Relations &
Deutsch English


Ken Livak, Fluidigm to Speak at Single Cell Analysis Conference, May 22-23, 2014, in Cambridge, MA

Print article Print article
2014-02-10 07:54:26 - Ken Livak, Senior Scientific Fellow at Fluidigm will give a featured presentation titled, “Driving Genomics to the Single-Cell Level: RNA Expression Profiling Using qPCR and RNAseq,” at the Inaugural Single Cell Analysis Conference to be held in Cambridge, MA on May 22-23, 2014 by GTC.

Ken Livak’s talk will cover:

• The nature of eukaryotic transcription in single cells
• How microfluidics can be used to obtain data from enough genes and enough cells to be
statistically relevant
• Overview of statistical methods needed to address the noise inherent in single-cell
• Highlights of recent research that illustrate emerging principles of how to analyze single
cell RNA expression data

Dr. Livak is Senior Scientific Fellow at Fluidigm and is charged with pioneering novel assays on Fluidigm microfluidic platforms. His current focus is on enabling robust quantification of RNA transcripts in single cells. He has recently relocated to the Boston area to help spearhead a Single Cell Genomics initiative in partnership with the Broad Institute.

Prior to joining Fluidigm, Dr. Livak spent 13 years at Applied Biosystems improving the robustness and versatility of using fluorogenic (TaqMan) probes in the 5’ nuclease PCR assays and coordinating scientific efforts across all instrument platforms. He has 30 issued U. S. Patents and 59 peer-reviewed publications.

For more information, please visit

Contact Information:

635 W. Foothill Blvd. Monrovia, CA 91016

Contact Person:
Kristen Starkey

Phone: 6262566405
email: email


Rania hafez
Phone: 626-256-6405

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact